Fellow Eye as a Predictor for Keratoconus Progression Following Accelerated Corneal Cross-linking.

PURPOSE To assess the fellow eye as a predictor for keratoconus progression following bilateral same-day accelerated corneal cross-linking (A-CXL). METHODS This was a post-hoc analysis of data from a prospective study of bilateral A-CXL for progressive keratoconus between 2013 and 2015. The primary outcome measures were absolute change in maximum keratometry (Kmax) (diopters [D]), relative change in Kmax (%), and A-CXL progression (increase in Kmax > 2.00 D). Responses in both eyes were measured by the change in Kmax, with the right eye serving as the "predictor" of progression for the left eye. RESULTS Three-hundred ninety-two eyes (196 patients) with a mean age of 26.8 ± 7.7 years were included. There was a significant correlation in absolute and relative Kmax change (r = 0.26, P < .001 and r = 0.32, P < .001, respectively) between right and left eyes. In regression analysis, the only significant predictors of change in Kmax in the left eye were preoperative Kmax of the left eye (P < .02) and change in Kmax of the right eye (P < .001). Eyes that progressed in the right eye were more likely to progress in the left eye (29.4% versus 4.5%, odds ratio = 8.85, P < .001). In multiple regression, right eye progression of greater than 2.00 D was the significant predictor of left eye progression of greater than 2.00 D (odds ratio = 15.15, P < .007). CONCLUSIONS This large-scale study of keratoconus following A-CXL indicates that patients with progression in the right eye were 15.5 times more likely to have progression in the left eye. Patients with progression following A-CXL in one eye should be closely observed due to increased risk of progression in the fellow eye. [J Refract Surg. 2021;37(3):186-191.].

[1]  W. Hatch,et al.  Accelerated corneal cross-linking: Efficacy, risk of progression, and characteristics affecting outcomes. A large single-centre prospective study. , 2020, American journal of ophthalmology.

[2]  Terry Kim,et al.  Corneal crosslinking: Current protocols and clinical approach. , 2019, Journal of cataract and refractive surgery.

[3]  Sumitra S. Khandelwal,et al.  Comparative Functional Outcomes After Corneal Crosslinking Using Standard, Accelerated, and Accelerated With Higher Total Fluence Protocols , 2019, Cornea.

[4]  A. Rednik,et al.  10-Year Results of Standard Cross-Linking in Patients with Progressive Keratoconus in Romania , 2019, Journal of ophthalmology.

[5]  A. Kheirkhah,et al.  Floppy eyelid syndrome: A comprehensive review. , 2020, The ocular surface.

[6]  R. D. Stulting,et al.  Corneal crosslinking without epithelial removal. , 2018, Journal of cataract and refractive surgery.

[7]  P. Hersh,et al.  Transepithelial corneal crosslinking for keratoconus. , 2018, Journal of cataract and refractive surgery.

[8]  N. Bussières,et al.  Keratoconus Asymmetry between Both Eyes Based on Corneal Tomography , 2017, Middle East African journal of ophthalmology.

[9]  R. D. Stulting,et al.  United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment. , 2017, Ophthalmology.

[10]  W. A. Abou Samra,et al.  Predictive Factors of the Standard Cross-linking Outcomes in Adult Keratoconus: One-Year Follow-Up , 2017, Journal of ophthalmology.

[11]  Guoying Mu,et al.  Outcomes of corneal crosslinking for central and paracentral keratoconus , 2017, Medicine.

[12]  K. Tekin,et al.  Effect of preoperative factors on visual acuity, corneal flattening, and corneal haze after accelerated corneal crosslinking , 2016, Journal of cataract and refractive surgery.

[13]  C. McGhee,et al.  Contemporary Treatment Paradigms in Keratoconus , 2015, Cornea.

[14]  M. Millodot,et al.  The Genetic and Environmental Factors for Keratoconus , 2015, BioMed research international.

[15]  A. Hassidim,et al.  Keratoconus and Allergic Diseases Among Israeli Adolescents Between 2005 and 2013 , 2015, Cornea.

[16]  P. McDonnell,et al.  Corneal collagen cross-linking for treating keratoconus. , 2015, The Cochrane database of systematic reviews.

[17]  G. Cherfan,et al.  Rate of Corneal Collagen Crosslinking Redo in Private Practice: Risk Factors and Safety , 2015, Journal of ophthalmology.

[18]  A. van der Lelij,et al.  A multivariate analysis and statistical model for predicting visual acuity and keratometry one year after cross-linking for keratoconus. , 2014, American journal of ophthalmology.

[19]  V. Yaylalı,et al.  Factors affecting outcomes of corneal collagen crosslinking treatment , 2014, Eye.

[20]  S. Greenstein,et al.  Characteristics influencing outcomes of corneal collagen crosslinking for keratoconus and ectasia: Implications for patient selection , 2013, Journal of cataract and refractive surgery.

[21]  Theo Seiler,et al.  Complication and failure rates after corneal crosslinking , 2009, Journal of cataract and refractive surgery.

[22]  Theo Seiler,et al.  Collagen crosslinking with ultraviolet‐A and hypoosmolar riboflavin solution in thin corneas , 2009, Journal of cataract and refractive surgery.

[23]  R. D. Stulting,et al.  Asymmetric Keratoconus Attributed to Eye Rubbing , 2004, Cornea.

[24]  T. Seiler,et al.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.

[25]  K. Zadnik,et al.  Between-Eye Asymmetry in Keratoconus , 2002, Cornea.